Real-Time Histopathology with Multimodal Nonlinear Imaging
11 September 2025 10:00 - 11:00
Join Michel Bégin, Product Line Manager at indie (TeraXion), and Kayvan Forouhesh, CEO of Eleuthra Photonics, as they reveal how lasers and AI are transforming real-time, stain-free histopathology for faster, more precise diagnostics.
The webinar "Real-time Histopathology with Multimodal Nonlinear Imaging " presents a breakthrough in digital pathology through the integration of the VINCI-1064 femtosecond laser with Eleuthra Photonics’ TetraQuant™ platform. It highlights how nonlinear optical techniques like SHG, THG, and autofluorescence enable label-free, real-time imaging without the need for staining, preserving tissue integrity and accelerating diagnostics. The presentation addresses technical challenges such as weak signal intensity and photodamage, and demonstrates how the compact, high-peak-power VINCI-1064 laser overcomes these barriers. The TetraQuant™ system offers a portable, AI-enhanced solution that supports both clinical and research applications, particularly in oncology and tissue analysis.
Sponsored By:
Co-Presenter By:
Speakers
Michel Bégin
Product Line Manager | Indie (TeraXion)
Michel Bégin is a seasoned product management leader with over 20 years of experience in high-technology sectors, including photonics, laser systems, and advanced manufacturing. At indie, he leads the ultrashort pulse laser product line, overseeing the development of cutting-edge femtosecond laser solutions such as the VINCI series.
Michel specializes in bringing innovative technologies to market by aligning technical development with real-world customer needs. He holds a Master’s degree in Electrical Engineering from Polytechnique Montréal and a Bachelor’s in Engineering Physics from Université Laval. His deep technical expertise and market-driven approach have made him a key player in advancing next-generation laser technologies.
Kayvan Forouhesh Tehrani
CEO | Eleuthra Photonics Inc.
About Kayvan Forouhesh Tehrani
Kayvan Tehrani, an optical engineer and researcher, is the founder of Eleuthra Photonics, specializing in nonlinear optics histopathology. With an extensive background in physics and engineering and recognized by an NIH fellowship, Kayvan's research focuses on enhancing microscopy, label-free tissue analysis, and discovering new optical biomarkers for diseases such as cancer and Alzheimer's.
His entrepreneurial pursuit is dedicated to advancing digital histopathology through the creation of a groundbreaking imaging tool engineered for swift, label-free examination of tissue samples. This innovative technology promises to significantly reduce diagnostic turnaround times from days to minutes, enhancing both the speed and accuracy of cancer diagnostics.
This cutting-edge technology mitigates potential diagnostic errors associated with conventional histopathological techniques and data interpretation methods by eliminating the necessity for chemical stains and furnishing multi-dimensional quantitative datasets. This expedites the diagnostic process and augments the precision of cancer diagnoses, thereby facilitating the development of more tailored and efficient treatment plans for patients.